The store will not work correctly when cookies are disabled.
4-(3-(4-(hydroxy(phenyl)methyl)piperidin-1-yl)propoxy)benzonitrile
ID: ALA3126179
PubChem CID: 46926612
Max Phase: Preclinical
Molecular Formula: C22H26N2O2
Molecular Weight: 350.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(OCCCN2CCC(C(O)c3ccccc3)CC2)cc1
Standard InChI: InChI=1S/C22H26N2O2/c23-17-18-7-9-21(10-8-18)26-16-4-13-24-14-11-20(12-15-24)22(25)19-5-2-1-3-6-19/h1-3,5-10,20,22,25H,4,11-16H2
Standard InChI Key: SYUGIOGEWUGFJR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
15.6174 -8.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8002 -8.3329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3903 -9.0346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7931 -9.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6103 -9.7491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0247 -9.0429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5732 -9.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1691 -8.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5831 -7.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1798 -6.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3617 -6.9008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9487 -7.6108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3544 -8.3178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8419 -9.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2531 -8.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0703 -8.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4815 -7.6364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2987 -7.6394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7010 -8.3473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5174 -8.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9294 -7.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5191 -6.9323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7040 -6.9325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7463 -7.6480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5635 -7.6499 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1600 -9.7344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
3 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
6 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
24 25 3 0
21 24 1 0
7 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.46 | Molecular Weight (Monoisotopic): 350.1994 | AlogP: 3.77 | #Rotatable Bonds: 7 |
Polar Surface Area: 56.49 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.82 | CX LogP: 3.31 | CX LogD: 1.88 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.77 | Np Likeness Score: -1.17 |
References
1. He S, Senter TJ, Pollock J, Han C, Upadhyay SK, Purohit T, Gogliotti RD, Lindsley CW, Cierpicki T, Stauffer SR, Grembecka J.. (2014) High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction., 57 (4): [PMID:24472025] [10.1021/jm401868d] |